Statistical issues arising in the Women's Health Initiative

Biometrics

Volumn 61, Issue 4, 2005, Pages 899-911

  Prentice, Ross L ^a   Pettinger, Mary ^a   Anderson, Garnet L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Chronic disease prevention; Clinical trial monitoring; Genome wide scan; Hazard ratio; Measurement error; Nutritional epidemiology; Observational study; Randomized controlled trial; Women's health

Indexed keywords

DISEASE CONTROL; DISEASES; GENES; HAZARDS; MEASUREMENT ERRORS; NUTRITION;

CHRONIC DISEASE; CHRONIC DISEASE PREVENTION; CLINICAL TRIAL; CLINICAL TRIAL MONITORING; DISEASE PREVENTION; GENOME-WIDE SCAN; HAZARD RATIO; NUTRITIONAL EPIDEMIOLOGY; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL; WOMEN'S HEALTH;

GENOME;

CALCIUM; CONJUGATED ESTROGEN; ESTROGEN; HORMONE ANALOG; MEDROXYPROGESTERONE; PROGESTERONE; VITAMIN D;

CARDIOVASCULAR DISEASE; ERROR ANALYSIS; GENOMICS; HORMONE; MODELING; STATISTICAL CONCEPT; WOMENS HEALTH;

BREAST TENDERNESS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLORECTAL CANCER; DATA ANALYSIS; ENDOMETRIUM CANCER; ERROR; GENOME; HAZARD ASSESSMENT; HEALTH STATUS; HIP FRACTURE; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MEASUREMENT; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; METHODOLOGY; MONITORING; NUTRITIONAL ASSESSMENT; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROTEOMICS; REVIEW; STATISTICAL ANALYSIS; STROKE; TIME; VAGINA BLEEDING; VENOUS THROMBOEMBOLISM; AGED; CONTROLLED CLINICAL TRIAL; FEMALE; LONGITUDINAL STUDY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; UNITED STATES; WOMEN'S HEALTH;

AGED; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS; UNITED STATES; WOMEN'S HEALTH;

EID: 33644867395     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.0006-341X.2005.454_1.x     Document Type: Review

References (61)

1. Anderson, G. L., Manson, J., Wallace, R., Lund, B., Hall, D., Davis, S., Shumaker, S., Wang, C. Y., Stein, E., and Prentice, R. L. ( 2003). Implementation of the Women's Health Initiative study design. Annals of Epidemiology 13, 5 17.
2. Angrist, J. D., Imbens, G. W., and Rubin, D. B. ( 1996). Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91, 444 455.
3. Barratt, B. J., Payne, F., Rance, H. E., Nutland, S., Todd, J. A., and Clayton, D. G. ( 2002). Identification of the sources of error in allele frequency estimations from pooled DNA indicates an optimal experimental design. Annals of Human Genetics 66, 393 405.
4. Barrett-Conner, E. and Grady, D. ( 1998). Hormone replacement therapy, heart disease, and other considerations. Annual Review of Public Health 19, 55 72.
5. Bingham, S. A. ( 2002). Biomarkers in nutritional epidemiology. Public Health Nutrition 5, 821 827.
6. Bingham, S. A., Luben, R., Welch, A., Wareham, N., Khaw, K. T., and Day, N. ( 2003). Are imprecise methods obscuring a relationship between fat and breast cancer? Lancet 362, 212 214.
7. Boyd, N. F., Stone, J., Vogt, K. N., Connelly, B. S., Martin, L. J., and Minkin, S. ( 2003). Dietary fat and breast cancer revisited: A meta-analysis of the published literature. British Journal of Cancer 89, 1672 1685.
8. Breslow, N. E. and Day, N. E. ( 1987). Statistical Methods for Cancer Research 2. The Design and Analysis of Cohort Studies. IARC Scientific Publication 82. Lyon, France : International Agency for Research on Cancer.
9. Calle, E. E., Rodriquez, C., Walker-Thurmond, K., and Thun, M. J. ( 2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 348, 1625 1638.
10. Carroll, R. J., Ruppert, D., and Stefanski, L. A. ( 1995). Measurement Error in Nonlinear Models. New York : Chapman and Hall.
11. Creasman, W. T., Hoel, D., and DiSaia, P. J. ( 2003). WHI: Now that the dust has settled: A commentary. American Journal of Obstetric Gynecology 189, 621 626.
12. Cuzick, J., Edwards, R., and Segnan, N. ( 1997). Adjusting for non-compliance and contamination in randomized clinical trials. Statistics in Medicine 16, 1017 1029.
13. Diamandis, E. P. ( 2004). Analysis of serum proteomic patterns for early cancer diagnostics: Drawing attention to potential problems. Journal of the National Cancer Institute 96, 353 356.
14. Downes, K., Barratt, B. J., Akan, P., Bumpstead, S. J., Taylor, S. D., Clayton, D. G., and Deloukas, P. ( 2004). SNP allele frequency estimation in DNA pools and variance component analysis. Biotechniques 36, 840 845.
15. The End of the Age of Estrogen [cover story] 2002). Newsweek July 22.
16. Fahrmeir, L. and Klinger, A. ( 1998). A nonparametric multiplicative hazard model for event history analysis. Biometrika 85, 581 592.
17. Feng, Z., Prentice, R. L., and Srivastava, S. ( 2004). Research issues and strategies for genomic and proteomic biomarker discovery and validation: A statistical perspective. Pharmacogenomics 5, 709 719.
18. Frangakis, C. E. and Rubin, D. B. ( 1999). Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment non-compliance and subsequent missing outcomes. Biometrika 86, 365 379.
19. Freedman, L. S., Anderson, G. L., Kipnis, V., Prentice, R. L., Wang, C. Y., Rossouw, J. R., Wittes, J., and DeMets, D. ( 1996). Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative. Controlled Clinical Trials 17, 509 525.
20. Gabriel, S. B., Schaffner, S. F., Nguyen, H., et al 2003). The structure of haplotype blocks in the human genome. Science 296, 2225 2229.
21. Gibbs, R. A., Belmont, J. W., Hardenbol, P., et al 2003). The International HapMap Consortium. The International HapMap Project. Nature 426, 789 796.
22. Goodman, D., Goldzieher, J., and Ayala, C. ( 2003). Critique of the report from the Writing Group of the WHI. Menopausal Medicine 10, 1 4.
23. Grady, D., Rubin, S. B., Pettiti, D. B., et al 1992). Hormone therapy to prevent disease and prolong life in post-menopausal women. Annals of Internal Medicine 117, 1016 1037.
24. Greenwald, P. ( 1999). Role of dietary fat in the causation of breast cancer: Point. Cancer Epidemiology Biomarkers and Prevention 8, 3 7.
25. Grodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., and Stampfer, M. J. ( 2000). A prospective observational study of post-menopausal hormone therapy and primary presentation of cardiovascular disease. Annals of Internal Medicine 133, 933 941.
26. Grodstein, F., Clarkson, T. B., and Manson, J. E. ( 2003). Understanding the divergent data on post-menopausal hormone therapy. New England Journal of Medicine 348, 645 650.
27. Hebert, J. R., Clemow, L., Pbert, L., Ockene, I. S., and Ockene, J. K. ( 1995). Social desirability bias in dietary self-report may compromise the validity of dietary intake measures. International Journal of Epidemiology 24, 389 398.
28. Heitmann, B. L. and Lissner, L. ( 1995). Dietary underreporting by obese individuals: Is it specific or non-specific? British Medical Journal 311, 986 989.
29. Herrington, D. M. and Howard, T. D. ( 2003). From presumed benefits potential harm - Hormone therapy and heart disease. New England Journal of Medicine 349, 519 521.
30. Huang, Y. and Wang, C. Y. ( 2000). Cox regression with accurate covariates unascertainable: A nonparametric correction approach. Journal of the American Statistical Association 45, 1209 1219.
31. Hunter, D. J. ( 1999). Role of dietary fat in the causation of breast cancer: Counter-point. Cancer Epidemiology Biomarkers and Prevention 8, 9 13.
32. Kaaks, R., Ferrari, P., Ciampi, A., Plummer, M., and Riboli, E. ( 2002). Uses and limitations of statistical accounting for random error correlations, in the validation of dietary questionnaire assessments. Public Health Nutrition 5, 969 976.
33. Kalbfleisch, J. D. and Prentice, R. L. ( 2002). The Statistical Analysis of Failure Time Data, 2nd edition. New York : John Wiley and Sons.
34. Kipnis, V., Subar, A. F., Midthune, D., et al 2003). Structure of dietary measurement error: Results of the OPEN biomarker study. American Journal of Epidemiology 158, 14 21.
35. Kruglyak, L. ( 1999). Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nature Genetics 22, 139 144.
36. Langer, R. D., White, E., Lewis, C. E., Kotchen, J. M., Hendrix, S. L., and Trevisan, M. ( 2003). The Women's Health Initiative observational study: Baseline characteristics of participants and reliability of baseline measures. Annals of Epidemiology 13, S107 S121.
37. Le Hellard, S., Ballereau, S. J., Visscher, P. M., et al 2002). SNP genotyping on pooled DNAs: Comparison of genotyping technologies and a semi-automated method for data storage and analysis. Nucleic Acids Research 30, 1 10.
38. Manson, J. E., Hsia, J., Johnson, K. C., et al., for the Women's Health Initiative Investigators 2003). Estrogen plus progestin and the risk of coronary heart disease. New England Journal of Medicine 349, 523 534.
39. Michels, K. B. and Manson, J. E. ( 2003). Postmenopausal hormone therapy: A reversal of fortune. Circulation 107, 1830 1833.
40. Mohlke, K. L., Erdos, M. R., Scott, L. J., et al 2002). High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools. Proceedings of the National Academy of Sciences of the United States of America 99, 16928 16933.
41. Naftolin, F., Taylor, H. S., Karas, R., et al 2004). The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertility and Sterility 81, 1498 1501.
42. Prentice, R. L. ( 2004). Chronic disease prevention: Public health potential and research needs. Statistics in Medicine 23, 3409 3420.
43. Prentice, R. L. and Anderson, G. ( 2005). Women's Health Initiative: Statistical aspects and early results. In Encyclopedia of Clinical Trials, 2nd edition, P. Armitage and T. Colton ( eds). New York : Wiley.
44. Prentice, R. L., Sugar, E., Wang, C. Y., Neuhouser, M., and Patterson, R. ( 2002). Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease. Public Health Nutrition 5, 977 984.
45. Prentice, R. L., Willett, W. C., Greenwald, P., et al 2004). Nutrition and physical activity and chronic disease prevention: Research strategies and recommendations. Journal of the National Cancer Institute 96, 1276 1287.
46. Prentice, R. L., Langer, R., Stefanick, M., et al 2005). Combined postmenopausal hormone therapy and cardiovascular disease: Toward resolving the discrepancy between the observational studies and the Women's Health Initiative clinical trial. American Journal of Epidemiology 162, 1 11.
47. Ray, W. A. ( 2003). Evaluating medication effects outside of clinical trials: New-user designs. American Journal of Epidemiology 158, 915 920.
48. Sagatopan, J. M., Venkatraman, E. S., and Begg, C. B. ( 2004). Two-stage designs for gene-disease association studies with sample size constraints. Biometrics 60, 589 597.
49. Schoeller, D. A. ( 2002). Validation of habitual energy intake. Public Health Nutrition 5, 883 888.
50. Sham, P., Bader, J. S., Craig, I., O'Donovan, M., and Owen, M. ( 2002). DNA pooling: A tool for large-scale association studies. Nature Reviews Genetics 3, 862 871.
51. Simon, R., Radmacher, M. D., Dobbin, K., and McShane, L. M. ( 2003). Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. Journal of the National Cancer Institute 95, 14 18.
52. Stampfer, M. and Colditz, G. ( 1991). Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Preventive Medicine 20, 47 63.
53. Subar, A. F., Kipnis, V., Troiano, R. P., et al 2003). Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: The OPEN study. American Journal of Epidemiology 158, 1 13.
54. Tibshirani, R. and Efron, B. ( 2002). Pre-validation and inference in microarrays. Statistical Applications in Genetics and Molecular Biology 1, Article 1, The Berkeley Electronic Press, http://www.bepress.com/sagmb.
55. The Truth about Hormones [cover story] 2002). Time July 22.
56. Whittemore, A. S. and McGuire, V. ( 2003). Observational studies and randomized studies of hormone replacement therapy: What can we learn from them? Epidemiology 14, 8 10.
57. Willett, W. C., Sampson, L., Stampfer, M. J., et al 1985). Reproducibility and validity of a semiquantitative food frequency questionnaire. American Journal of Epidemiology 122, 51 65.
58. Women's Health Initiative Steering Committee 2004). Effects of conjugated equine estrogen in post-menopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 291, 1701 1712.
59. Women's Health Initiative Study Group 1998). Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials 19, 61 109.
60. Writing Group for the Women's Health Initiative Investigators 2002). Risks and benefits of estrogen plus progestin in healthy post-menopausal women. Principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288, 321 333.
61. Yang, S. and Prentice, R. L. ( 2005). Semiparametric analysis of short-term and long-term relative risks with two sample survival data. Biometrika 92, 1 17.